Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RET (Rearranged during Transfection) is a receptor tyrosine kinase that serves as the main signaling receptor for glial cell line-derived neurotrophic factor (GDNF) and other GDNF family ligands (GFLs). It plays critical roles in neuronal survival, development, and maintenance, as well as in kidney morphogenesis and the enteric nervous system. Ligand binding occurs via a co-receptor complex: GDNF first binds to a glycosylphosphatidylinositol-linked co-receptor called GFRα1. The resulting complex then interacts with and activates the transmembrane tyrosine kinase activity of RET. Upon activation, intracellular signaling cascades are triggered—most notably: MAPK/ERK pathway, PI3K/AKT pathway, Src-family kinases pathway.
RET activation by GDNF supports the survival of dopaminergic and motor neurons, stimulates branching and proliferation of embryonic kidneys, and is crucial during development of the enteric nervous system. Small molecule agonists target RET for neuroprotective effects and modulation of glial activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glial cell-line derived neurotrophic factor receptor RET.